pcess609/iStock via Getty Images
As top pharmaceutical executives descend on San Francisco, CA, to attend the JP Morgan Healthcare conference next week, biotech deals will be in focus as the annual event typically coincides with major M&A announcements.
Along with Big Pharma, it faces a significant patent
